Clinical and virological monitoring during treatment with intrathecal cytarabine in patients with AIDS-associated progressive multifocal leukoencephalopathy

Clinical Infectious Diseases

Volumn 28, Issue 3, 1999, Pages 624-628

  De Luca, Andrea ^a   Giancola, Maria Letizia ^a   Cingolani, Antonella ^a   Ammassari, Adriana ^a   Gillini, Laura ^a   Murri, Rita ^a   Antinori, Andrea ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CYTARABINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BLOOD TOXICITY; CLINICAL ARTICLE; DISEASE ACTIVITY; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HUMAN; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; JC VIRUS; LYMPHOCYTE COUNT; MALE; PATIENT MONITORING; PRIORITY JOURNAL; PROGNOSIS; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; SURVIVAL TIME; TREATMENT OUTCOME; VIRUS DETECTION; VIRUS LOAD;

EID: 0033051395     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/515153     Document Type: Article

References (23)

1. 1. Berger JR, Kaszovitz B, Post MJ, Dickinson G. Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection: a review of the literature with a report of sixteen cases. Ann Intern Med 1987;107:78-87.
2. 2. Berger JR, Mucke L. Prolonged survival and partial recovery in AIDS-associated progressive multifocal leukoencephalopathy. Neurology 1988;38:1060-5.
3. 3. Fong IW, Toma E. The natural history of progressive multifocal leukoencephalopathy in patients with AIDS. Clin Infect Dis 1995;20: 1305-10.
4. 4. Portegies P, Algra PR, Hollak CE, et al. Response to cytarabine in progressive multifocal leukoencephalopathy in AIDS. Lancet 1991;337: 680-1.
5. 5. Nicoli F, Chave B, Peragut JC, Gastaut JL. Efficacy of cytarabine in progressive multifocal leukoencephalopathy in AIDS. Lancet 1992;339: 306.
6. 6. Antinori A, De Luca A, Ammassari A, et al. Failure of cytarabine and increased JC virus DNA burden in the cerebrospinal fluid of patients with AIDS-related progressive multifocal leukoencephalopathy. AIDS 1994;8:1022-4.
7. 7. Moreno S, Miralles P, Diaz D, et al. Cytarabine therapy for progressive multifocal leukoencephalopathy in patients with AIDS. Clin Infect Dis 1996;23:1066-8.
8. 8. Hall C, Dafni U, Simpson D, et al. Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. N Engl J Med 1998;338:1343-51.
9. 9. Conway B, Halliday WC, Brunham RC. Human immunodeficiency virus-associated progressive multifocal leukoencephalopathy: apparent response to 3′-azido-3′-deoxythymidine. Rev Infect Dis 1990;12: 479-82.
10. 10. Power C, Nath A, Aoki FY, Bigio MD. Remission of progressive multifocal leukoencephalopathy following splenectomy and antiretroviral therapy in a patient with HIV infection. N Engl J Med 1997;336:661-2.
11. 11. Elliot B, Aromin I, Gold R, Flanigan T, Mileno M. 2.5 year remission of AIDS-associated progressive multifocal leukoencephalopathy with combined antiretroviral therapy. Lancet 1997;349:850.
12. 12. Domingo P, Guardiola JM, Iranzo A, Margall N. Remission of progressive multifocal leukoencephalopathy after antiretroviral therapy. Lancet 1997;349:1554-5.
13. 13. Baqi M, Kucharczyk W, Walmsley SL. Regression of progressive multi-focal encephalopathy with highly active antiretroviral therapy. AIDS 1997;11:1526-7.
14. 14. Albrecht H, Hoffmann C, Degen O, et al. Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy. AIDS 1998;12: 1149-54.
15. 15. Jacobson MA, French M. Altered natural history of AIDS-related opportunistic infections in the era of potent combination antiretroviral therapy. AIDS 1998; 12(suppl A):S157-63.
16. 16. Miralles P, Padilla B, Berenguer J, et al. Therapy of AIDS-associated progressive multifocal leukoencephalopathy with protease inhibitors combination regimens [abstract 464]. In: Program and abstracts of the 5th Conference on Retroviruses and Opportunistic Infections (Chicago). Alexandria, VA: Foundation for Retrovirology and Human Health, 1998.
17. 17. De Luca A, Cingolani A, Linzalone A, et al. Improved detection of JC virus DNA in cerebrospinal fluid for diagnosis of AIDS-related progressive multifocal leukoencephalopathy. J Clin Microbiol 1996;34:1343-6.
18. 18. Antinori A, Ammassari A, De Luca A, et al. Diagnosis of AIDS-related focal brain lesions: a decision-making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays in CSF. Neurology 1997;48:687-94.
19. 19. Matsiota-Bernard P, De Truchis P, Gray F, Flament-Saillour M, Voyatzakis E, Nauciel C. JC virus detection in the cerebrospinal fluid of AIDS patients with progressive multifocal leukoencephalopathy and monitoring of the antiviral treatment by a PCR method. J Med Microbiol 1997;46:256-9.
20. 20. Piliero PJ, Nguyen AD, Reif M. Fatal progressive multifocal leukoencephalopathy despite highly active antiretroviral therapy, interferon-alpha 2b and peptide T [abstract 466]. In: Program and abstracts of the 5th Conference on Retroviruses and Opportunistic Infections (Chicago). Alexandria, VA: Foundation for Retrovirology and Human Health, 1998.
21. 21. Brodt HR, Kamps BS, Gute P, Knupp B, Staszewski S, Helm EB. Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy. AIDS 1997;11:1731-8.
22. 22. Cinque P, Baldanti F, Vago L. Ganciclovir in cytomegalovirus (CMV) infection of the central nervous system in AIDS patients: monitoring by CMV DNA detection in cerebrospinal fluid. J Infect Dis 1995;171: 1603-6.
23. 23. Blick G, Whiteside M, Griegor P, Hopkins U, Garton T, LaGravinese L. Successful resolution of progressive multifocal leukoencephalopathy after combination therapy with cidofovir and cytosine arabinoside. Clin Infect Dis 1998;26:191-2.